SCHEMBL14060702

SCHEMBL14060702

CC(=O)[C@@H](O)[C@H](O)[C@H](O)[C@H](C)O

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2469150 1.00 TP53 (0.33) TP53
SCHEMBL26715533 1.00 TP53 (0.33) TP53
SCHEMBL6027888 1.00 TP53 (0.33) TP53
SCHEMBL7154730 1.00 TP53 (0.33) TP53
SCHEMBL3729926 1.00 TP53 (0.33) TP53
SCHEMBL17570468 0.97 TP53 (0.32) TP53
Acetic Acid SCHEMBL27945447 0.95 FFAR3 (0.37) TP53
SCHEMBL13703412 0.91 TP53 (0.35) TP53
SCHEMBL12572606 0.87 LMNA (0.36) TP53
SCHEMBL13997319 0.87 LMNA (0.36) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012160337-A1 SULFATED OLIGOSACCHARIDES FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES KINGS COLLEGE LONDON (GB) 2012-11-29 WO claimed
CN-109477078-A It is carried out using genetically modified fungal cell improved from the generation of the meso galactosaccharic acid of galacturonic acid 芬兰国家技术研究中心股份公司 2019-03-15 CN disclosed
WO-2012160337-A1 SULFATED OLIGOSACCHARIDES FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES KINGS COLLEGE LONDON (GB) 2012-11-29 WO disclosed